Fortschritt Healthcare
FORTSCHRITTHealthcare Limited
biotechResearch & Development

R&D Publications

Peer-reviewed research and scientific publications from Fortschritt Healthcare's R&D division.

Formulation2023

Bioavailability Enhancement of BCS Class II Drugs via Solid Dispersion Techniques

Authors: R. Sharma, P. Gupta, M. Kapoor

Journal of Pharmaceutical Sciences

Oncology2023

Novel Approach to Targeted Drug Delivery in Oncology Using Polymeric Nanoparticles

Authors: A. Singh, S. Mehta, R. Verma

Drug Delivery & Translational Research

Quality2022

Stability Studies of Critical Parenteral Formulations Under ICH Q1A Guidelines

Authors: M. Patel, D. Joshi

AAPS PharmTech

Formulation2022

Development of Extended-Release Matrix Tablets for Cardiovascular Drug Delivery

Authors: P. Kumar, A. Nair

International Journal of Pharmaceutics

Analytics2021

Comparative Dissolution Studies of Generic vs. Branded Anti-infective Formulations

Authors: S. Bose, N. Rajput

Dissolution Technologies

R&D2021

Green Chemistry Approaches in API Synthesis — A Review

Authors: A. Chaturvedi, R. Menon

Organic Process Research & Development

science

Collaborate With Our R&D Team

Interested in joint research, licensing, or scientific collaboration? We welcome academic and industry partnerships.

Get in Toucharrow_forward